Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JTS2500041	ALXN1720注射液	gefurulimab	Injection	Biological Products	Disposable Import Drug Application	2025-06-12	Patheon Italia SpA;Alexion Europe SAS;AstraZeneca Global R&D (China) Co Ltd	view
JTS2500042	ALXN1720注射液	gefurulimab	Injection	Biological Products	Disposable Import Drug Application	2025-06-12	Patheon Italia SpA;Alexion Europe SAS;AstraZeneca Global R&D (China) Co Ltd	view
JXSL2300030	ALXN1720注射液	gefurulimab	Injection	Biological Products(1)	Import Drug Application	2023-02-02	Alexion Pharmaceuticals Inc;AstraZeneca Global R&D (China) Co Ltd	view
JXSL2200172	ALXN1720注射液	gefurulimab	Injection	Biological Products(1)	Import Drug Application	2022-09-24	Alexion Pharmaceuticals Inc;AstraZeneca Global R&D (China) Co Ltd	view